IONS FY 2017 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$12B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$514M+37.9% YoY

Gross Profit

$514M100.0% margin

Operating Income

$31M6.0% margin

Net Income

$346,0000.1% margin

EPS (Diluted)

$-0.05

Cash Flow

Operating Cash Flow

$174M

Free Cash Flow

$136M

Stock-Based Comp.

$86M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$957M

Stockholders' Equity

$281M

Cash & Equivalents

$130M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$514M	$373M	+37.9%
Gross Profit	$514M	$373M	+37.9%
Operating Income	$31M	-$20M	+254.0%
Net Income	$346,000	-$60M	+100.6%